4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000008
Chief Medical Officer sold 416 shares at $32.10 ($13,354)
- Chief Medical Officer acquired 416 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-01-20 | Option exercise 10b5-1 | +416 | $15.44 | $6,423 | 50,853 | D |
| Rodman David Malcom Chief Medical Officer | 2026-01-20 | Sale 10b5-1 | −416 | $32.10 | $13,354 | 50,437 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-01-20 | Option exercise · Stock Option 10b5-1 | −416 | 5,834 | D | ||
| Open-market sales · 416 sh · avg $32.10 · $13,354 | |||||||
Loading xslF345X05/wk-form4_1768959233.xml…